Sanofi Paid Doctors To Help Delay Lovenox Generic: Sens.

Law360, New York (May 25, 2011, 7:32 PM EDT) -- Sanofi-Aventis SA paid doctors to petition the U.S. Food and Drug Administration to delay approval of a generic blood thinner that would compete with its blockbuster drug Lovenox, according to a report released Wednesday by members of the Senate Finance Committee.

Sanofi paid $5.3 million to two medical advocacy groups and a medical professor to submit FDA citizen petitions raising safety concerns about alternatives to Lovenox, which has netted billions of dollars for the French pharmaceutical giant, the report said.

The company's hold on the market...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.